陶明

工作经历

2014年至今，北京大学第三医院普通外科住院医师、主治医师

科研工作

一、课题

1、教育部博士点基金（博导类），20130001110089、FAM176A在胰腺神经内分泌肿瘤中的作用研究、2014/01-2016/12、12万元、已结题、参加。

2、中国抗癌协会基金，Y-N2013-008、无功能胰腺神经内分泌肿瘤肝转移相关关键分子靶点筛选的初步研究、2014/01-2016/12、10万元、已结题、参加。

3、国家自然科学基金面上项目，30872556、大剂量化疗药诱导移植免疫耐受相关蛋白的筛查、鉴定及初步应用、2009/01-2011/12、34万元、已结题、参加。

4、教育部博士点基金（博导类），20090001110096、利用基因转染和时空特异性基因打靶技术体外提高胰岛可控性增殖能力、2009/01-2011/12、6万元、已结题、参加

5. 国家自然科学基金面上项目，81672862、TOPK调节Raf-1/MEK/ERK对胰腺神经内分泌肿瘤肝转移的影响及治疗靶点的初步研究、2017/01-2020/12/67.2万、在研、参加。

二、专利

陶明，负压吸引装置，2013-08-27，中国，ZL201320526489.7

陶明，内置骨架式组织冻存管，2013-12-05，中国，ZL201320797264.5

论文

1.Tao, Ming;Shi, Xue-Ying; Yuan, Chun-Hui;Hu, Jia;Ma, Zhao-Lai; Jiang, Bin;Xiu, Dian-Rong*; Chen, Ying-Yu*, Expression Profile and Potential Roles of EVA1A in Normal and Neoplastic Pancreatic Tissues., Asian Pac J Cancer Prev, 16(1), pp 373-376, 2015.

2.Tao, Ming;Yuan, Chunhui;Xiu, Dianrong*;Shi, Xueying;Tao, Liyuan; Ma, Zhaolai;Jiang, Bin;Zhang, Zhipeng;Zhang, Lingfu;Wang, Hangyan, Analysis of risk factors affecting the prognosis of pancreatic neuroendocrine tumors., Chinese Medical Journal, 127(16), pp 2924-2928, 2014.

3.M. Tao; D.R. Xiu*, Metabonomic Analysis of Rats With Acute Heart Rejection, Transplantation Proceedings, 45(2), pp 618-624, 2013/3.

4.Yuan, Chun-Hui; Tao, Ming; Jia, Yi-Mu; Xiong,Jing-Wei; Zhang, Tong-Lin; Xiu, Dian-Rong, Duodenum-preserving resection and Roux-en-Y pancreatic jejunostomy in benign pancreatic head tumors., World Journal of Gastroenterology, 20(44), pp 16786-16792, 2014/11/28.

5.Ye C, Chen Q, Wang H, Zhang Z, Zhang L, Tao M, Yuan C. Tao L, Xiu D, Sadula A, Surgical resection of primary tumor improves survival of pancreatic neuroendocrine tumor with liver metastases. Oncotarget. 2017 Jul 24;8(45):79785-79792.

6.Wang H,Xiu D, Tao M. The pancreatic juice length in the stent tube as the predicting factor of clinical relevant postoperative pancreatic fistula after pancreaticoduodenectomy. Medicine (Baltimore). 2017 Nov;96(44):e8451.

7.Zhang L,Xiu D, Zhan J, He X, Guo L, Wang J, Tao M, Fu W, Zhang H. High expression of muscarinic acetylcholine receptor 3 predicts poor prognosis in patients with pancreatic ductal adenocarcinoma. Onco Targets Ther. 2016 Oct 31;9:6719-6726.

8.Tao L, Zhang L, Peng Y, Tao M, Li L, Xiu D, Yuan C, Ma Z, Jiang B. Neutrophils assist the metastasis of circulating tumor cells in pancreatic ductal adenocarcinoma: A new hypothesis and a new predictor for distant metastasis. Medicine (Baltimore). 2016 Sep;95(39):e4932.

9.Zhang L, Guo L, Tao M, Fu W, Xiu D.Parasympathetic neurogenesis is strongly associated with tumor budding and correlates with an adverse prognosis in pancreatic ductal adenocarcinoma.Chin J Cancer Res. 2016 Apr;28(2):180-6.

10.Yuan CH, Wang J, Xiu DR, Tao M, Ma ZL, Jiang B, Li ZF, Li L, Wang L, Wang H, Zhang TL.Meta-analysis of Liver Resection Versus Nonsurgical Treatments for Pancreatic Neuroendocrine Tumors with Liver Metastases. Ann Surg Oncol. 2016 Jan;23(1):244-9.